Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.35 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.35 |
| ▸ | PRKCG | P05129 | 1/20 | 0.35 |
| ▸ | PRKCB | P05771 | 1/20 | 0.35 |
| ▸ | PRKCH | P24723 | 1/20 | 0.35 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.35 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.35 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.35 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.35 |
| ▸ | DAGLA | Q9Y4D2 | 10/20 | 0.35 |
| ▸ | CNR1 | P21554 | 8/20 | 0.35 |
| ▸ | DAGLB | Q8NCG7 | 3/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | ABHD16A | O95870 | 1/20 | 0.33 |
| ▸ | LPL | P06858 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | LIPC | P11150 | 1/20 | 0.33 |
| ▸ | PNLIP | P16233 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Antibiotic 1233A SCHEMBL285680 | 1.00 | PRKCA (0.35) | PRKCAPRKD3PRKCGPRKCBPRKCH | |
| Antibiotic 1233A SCHEMBL285679 | 1.00 | PRKCA (0.35) | PRKCAPRKD3PRKCGPRKCBPRKCH | |
| SCHEMBL10371410 | 0.88 | PRKCA (0.35) | PRKCAPRKD3PRKCGPRKCBPRKCH | |
| SCHEMBL713540 | 0.88 | PRKCA (0.35) | PRKCAPRKD3PRKCGPRKCBPRKCH | |
| SCHEMBL10371408 | 0.88 | PRKCA (0.35) | PRKCAPRKD3PRKCGPRKCBPRKCH | |
| SCHEMBL9659447 | 0.88 | DAGLA (0.35) | DAGLACNR1DAGLBMGLLMEN1 | |
| SCHEMBL713269 | 0.86 | DAGLA (0.34) | PRKCAPRKD3PRKCGPRKCBPRKCH | |
| SCHEMBL713268 | 0.86 | DAGLA (0.34) | PRKCAPRKD3PRKCGPRKCBPRKCH | |
| SCHEMBL9824730 | 0.85 | PRKCA (0.34) | PRKCAPRKD3PRKCGPRKCBPRKCH | |
| SCHEMBL6061849 | 0.83 | PRKCA (0.40) | PRKCAPRKD3PRKCGPRKCBPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 868 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3360220-B1 | MAXIMUM ENERGY UTILIZATION POINT TRACKING TECHNOLOGIES | LT USA CORP (US) | 2026-04-15 | — | — | EP | claimed |
| EP-4350447-B1 | ELECTROPHOTOGRAPHIC IMAGE FORMING DEVICE AND CARTRIDGE | CANON KK (JP) | 2025-08-20 | — | — | EP | claimed |
| EP-4312646-B1 | RELEASABLE SHOE FASTENING DEVICE | GCLIPROW INC (US) | 2025-04-30 | — | — | EP | claimed |
| EP-3944025-B1 | ELECTROPHOTOGRAPHIC IMAGE FORMING DEVICE AND CARTRIDGE | CANON KK (JP) | 2024-03-06 | — | — | EP | claimed |
| EP-3942601-A1 | ELECTRONIC MOLDED PACKAGE | Ampleon Netherlands B.V. (NL) | 2022-01-26 | — | — | EP | claimed |
| EP-1644399-A2 | NOVEL COMPOUNDS AND COMPOSITIONS COMPRISING STEROLS AND/OR STANOLS AND CHOLESTEROL BIOSYNTHESIS INHIBITORS AND USE THEREOF IN TREATING OR PREVENTING A VARIETY OF DISEASES AND CONDITIONS. | Forbes Medi-Tech Inc. (CA) | 2006-04-12 | — | — | EP | claimed |
| US-6982251-B2 | Substituted 2-azetidinones useful as hypocholesterolemic agents | SCHERING CORPORATION (US) | 2006-01-03 | — | — | US | claimed |
| WO-2005005453-A2 | NOVEL COMPOUNDS AND COMPOSITIONS COMPRISING STEROLS AND/OR STANOLS AND CHOLESTEROL BIOSYNTHESIS INHIBITORS AND USE THEREOF IN TREATING OR PREVENTING A VARIETY OF DISEASES AND CONDITIONS. | FORBES MEDI-TECH INC. (CA) | 2005-01-20 | — | — | WO | claimed |
| CN-116367907-B | Reusable filter system and frame, method of assembly and transportation thereof, and use thereof | WANG JIEFANG (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-122073902-A | Solar cell, photovoltaic module and preparation method of solar cell | 天合光能股份有限公司 | 2026-05-22 | — | — | CN | disclosed |
| EP-4744328-A1 | PDU SESSION WITH RAN SUPPORT IN A COMMUNICATION SYSTEM | GOOGLE LLC (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-4743331-A2 | SIDE IMPACT PROTECTION ON CAR SEAT | Wonderland Switzerland AG (CH) | 2026-05-20 | — | — | EP | disclosed |
| EP-4743333-A2 | SIDE IMPACT PROTECTION ON CAR SEAT | Wonderland Switzerland AG (CH) | 2026-05-20 | — | — | EP | disclosed |
| EP-4745675-A2 | ELECTROPHOTOGRAPHIC IMAGE FORMING DEVICE AND CARTRIDGE | Canon Kabushiki Kaisha (JP) | 2026-05-20 | — | — | EP | disclosed |
| US-6264938-B1 | ADMINISTERING POLYDIALLYLAMINE AND HYDROXY-3-METHYLGLUTARYL/3-/, COENZYME A REDUCTASE | GELTEX PHARMACEUTICALS, INC. | 2001-07-24 | — | — | US | disclosed |
| WO-2000069446-A1 | COMBINATION THERAPY FOR TREATING HYPERCHOLESTEROLEMIA | GELTEX PHARMACEUTICALS, INC. (US) | 2000-11-23 | — | — | WO | disclosed |
| CN-1255864-A | Combination of ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors | SEARLE & CO (US) | 2000-06-07 | — | — | CN | disclosed |
| US-5631365-A | TREATING LACTONE WITH BASE; REACTING WITH AROMATIC IMINE; LACTAMIZATION | SCHERING CORPORATION (US) | 1997-05-20 | — | — | US | disclosed |
| US-5624920-A | Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents | SCHERING CORPORATION (US) | 1997-04-29 | — | — | US | disclosed |
| EP-0766667-A1 | SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS | SCHERING CORPORATION (US) | 1997-04-09 | — | — | EP | disclosed |